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Distinct stages characterize the development of 
a naive CD8+ T cell into a memory T cell. A 
naive CD8+ T cell encounters its antigen, be-
comes activated, and while undergoing numer-
ous rounds of cell division diff  erentiates into an 
eff   ector cell capable of killing infected target 
cells (1). At the peak of the CD8+ T cell re-
sponse, antigen-specifi  c cells may have increased 
as much as 50,000-fold (2), but 90–95% of these 
cells undergo apoptosis over the course of the 
next 7–14 d. The remaining cells continue to 
diff   erentiate and establish an antigen-specifi  c, 
long-lived memory CD8 T cell population (1).
The requirements to successfully prime a 
naive T cell and guide it into the memory cell 
development pathway have been of long stand-
ing interest. In particular, the impact individual 
activation requirements might have on the size 
of the memory pool and on the quality of a sec-
ondary response is crucial for the development 
of better vaccines. It has become clear that to be 
fully activated a CD8+ T cell needs to receive 
three distinct signals: antigen, costimulation, 
and a signal 3 cytokine which can be provided 
by IL-12 or type I interferon (3–5). Several key 
studies have introduced the concept of T cell 
programming (6–10), which describes the phe-
nomenon that a brief encounter with antigen 
is suffi   cient to trigger a cell autonomous pro-
gram leading to proliferation and diff  erentiation 
into memory T cells. Ensuing studies further 
  addressed the time frame necessary to ensure 
  successful programming of a T cell (11–13). 
Stipdonk et al. (11) suggested that a very brief 
stimulation (4 h) would result in clonal abor-
tion, whereas a somewhat longer stimulus (20 h) 
leads to expansion. Curtsinger et al. showed 
that 6 or 18 h of in vitro stimulation in the pres-
ence of IL-12 was not suffi   cient  for  optimal 
  expansion and full development of eff  ector 
function, as they observed a substantial increase 
in CD8+ numbers and CTL activity when an-
tigen stimulation was prolonged to 64 h (14).
One caveat of these studies is the limitation 
of providing the initial timed antigenic stimu-
lus in vitro before transferring the cells into an 
antigen-free environment. Other studies over-
come this hurdle by controlling bacterial anti-
gen presentation in vivo through various 
treatment patterns with antibiotics, thus reduc-
ing infl  ammatory stimuli and the antigen load 
(6, 12, 13). The enhancing eff  ect of infl  am-
mation on eff  ector T cells independently of 
  antigen was documented by Busch et al. by 
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demonstrating that in vivo–generated CD8+ eff  ector T cells 
do undergo further short-term expansion in response to bac-
terial infection even in the absence of antigen (15). Collec-
tively, these studies suggest that in vivo programming of 
CD8+ T cells is completed within 36–60 h (assuming antibi-
otic clearance of the pathogen within 12 h), but they also 
underline the necessity of studying programming in a system 
that allows dissecting the role of the TCR stimulus from 
  infl  ammatory signals. Another complication of controlling 
bacterial antigen presentation by antibiotic treatment is that 
the timing cannot be precise. There is the potential of pro-
longed antigen presentation through cross-presentation, even 
in the absence of a detectable bacterial load. It is thus not 
clear if the T cells were indeed deprived of an antigen stimu-
lus after clearance of the bacteria 12–24 h after onset of the 
antibiotic treatment.
We wanted to overcome the limitations of previous 
studies and examine the concept of CD8+ programming in 
a defi  ned in vivo environment with close to physiological 
conditions while matching the effi   cient removal of antigen 
possible in in vitro experiments. Here, we used a system that 
allowed us to isolate the role of the TCR in programming, 
i.e., vary antigen exposure time while keeping constant 
other variables such as cytokine environment (16–18), na-
ture of the antigen-presenting cell and costimulatory mole-
cules (19, 20), and signal strength (21, 22). In addition to 
studying programming in vivo, we examined whether pa-
rameters encountered during the priming phase would be 
imprinted in these cells and subsequently aff  ect CD8+ T cell 
behavior in a secondary challenge. We report here that cells 
stimulated with antigen for a limited time display a limited 
potential to accumulate in the primary response but become 
Figure 1.  GFPhi DTR transgenic DCs are rapidly deleted by diphthe-
ria toxin. (A) 3.7 × 105 OVAp-pulsed, GFP-sorted DTRtg DCs were trans-
ferred i.v. and the mice were left untreated (left) or treated with DT at 12 h 
(middle) or 18 h (right) after transfer. 4 × 105 CFSE-labeled OT-I T cells 
were adoptively transferred 24 h after DC injection, and mice were har-
vested 3 d after OT-I transfer. Histograms shown are gated on OT-I T cells 
from an OT-I only control animal (gray) or the respective experimental 
groups (bold). (B) GFPhi and thus DTRhi-expressing DCs were sorted and 
used to assure responsiveness to the toxin. Pre-sort FACS plot shown is 
based on a spleen from a Flt3L-treated animal after depletion of T and B 
cells (see Material and methods). (C) 8 × 105 DCs from B6 or Kbm1 mice 
were pulsed with LPS (gray) or LPS + OVAp (bold) and transferred into B6 
recipients that received 106 naive OT-I T cells 24 h earlier. 3 d after trans-
fer of the DCs, the CFSE profi  le of the OT-I cells was used as a readout of 
T cell activation.JEM VOL. 203, September 4, 2006  2137 
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programmed to develop into memory cells that are fully 
functional in a rechallenge.
RESULTS
To study programming in vivo in an environment that mim-
ics physiological conditions as closely as possible, we devel-
oped a system that allowed us to study the eff  ects of varying 
the duration of antigen exposure to naive CD8+ T cells with-
out altering the infl  ammatory milieu in the host. This   enabled 
us to distinguish between cytokine-mediated and antigen-
mediated signals delivered to CD8+ T cells. In our system, 
antigen is delivered via adoptive transfer of an excess number 
of peptide-pulsed DCs isolated from mice carrying a GFP-
diphtheria toxin receptor transgene (DTRtg) expressed   under 
the CD11c promoter (23). Since rodent cells do not express 
the receptor for diphtheria toxin (DT), the transgenic DCs 
are the only cells susceptible to the toxin (24).
First, we tested the effi   ciency and kinetics of toxin-medi-
ated depletion of DCs by transferring 3.7 × 105 OVAp-
pulsed DTRtg DCs, followed by DT injections at diff  erent 
time points before transfer of 4 × 105 OT-I T cells 24 h later 
(Fig. 1 A). CFSE dilution on day 3 after transfer of the OT-I 
cells was used as an indicator of DC presence. The vast ma-
jority of peptide-pulsed antigen-presenting DCs is eliminated 
within 6 h of DT injection (Fig. 1 A, right, DT at 18 h), and 
virtually all DCs are eliminated within 12 h of DT injection 
(Fig. 1 A, DT at 12 h, middle and reference 25). Such effi   -
cient removal of DTRtg DCs depended on transferring 
sorted GFPhi CD11c+ cells (Fig. 1 B), i.e., DCs which are 
most sensitive to the toxin. In accord with reports in the lit-
erature (26–29) we did not observe cross-presentation of the 
peptide, as Kbm1 DCs pulsed with OVAp did not trigger 
OT-I proliferation (Fig. 1 C). Thus, antigen presentation is 
aborted with deletion of the DC, as also shown by the lack of 
Figure 2.  Varying the antigen exposure time affects the magni-
tude of the primary CD8+ T cell response. (A) A schematic of the 
adoptive transfer system. (B) 104 CD45.1 congenic, CFSE-labeled OT-I T 
cells were transferred with 3.7 × 105 SIINFEKL-pulsed DTRtg DCs, and DT 
was administered at the indicated time points. All experimental groups 
apart from the DTRtg DC, OT-I only, and B6 control groups received 2,000 
CFU WT-LM. The percentage of OT-I T cells in the spleen is shown. 
(C) Absolute numbers of OT-I T cells on day 5 of the groups shown in B. 
Note that the OT-I only animals received 100× more OT-I T cells than 
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antigen-specifi  c T cell proliferation after DT treatment (Fig. 
1 A). We furthermore confi  rmed that the priming ability of 
DTRtg DCs is not altered compared with WT DCs and that 
the toxin itself does not interfere with the CD8+ T cell re-
sponse (unpublished data).
As outlined in Fig. 2 A, we transferred 104 OT-I T cells 
together with 3.7 × 105 OVAp-pulsed DTRtg DCs and in-
fected the mice with WT-LM to provide a general infl  am-
matory environment (30). DT was administered 1, 12, 24, or 
48 h after OT-I/DC transfer, and mice were harvested on 
day 5 after challenge (Fig. 2 B). Although the 48 h DT group 
showed no diff  erence compared with the no toxin control, a 
reduction in OT-I numbers was observed in the 1-, 12-, and 
24-h groups in percentage and absolute numbers (Fig. 2, B 
and C). Thus, the longer antigen is presented the more OT-I 
T cells accumulate. Interestingly, mice that were not treated 
with DT and did not receive WT-LM (Fig. 2 B, DTRtg 
DC, no LM group) resemble the 12-h DT group in terms of 
Figure 3.  Varying the antigen exposure time does not affect 
CD8+ T cell functionality. (A) To determine traffi  cking properties, lungs 
of mice were harvested after perfusion of the animal and analyzed for 
the presence of OT-I T cells. The percentage of OT-I T cells in the lung is 
shown. (B) Splenocytes were tested for their ability to produce IFNγ in a 
4-h assay. Histograms are based on a gate specifi  c for the congenic OT-I 
T cells. (C) Splenic OT-I T cells were analyzed for CD62L surface expression 
on day 5. Naive OT-I control cells are shown in white, and OT-I T cells 
from the experimental groups are shown in gray.JEM VOL. 203, September 4, 2006  2139 
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OT-I numbers (Fig. 2 C), thus illustrating the enhancing ef-
fect provided by WT-LM infection. As a control, B6 mice 
received 106 OT-I T cells alone to determine the effi   ciency 
of the take, or no OT-I T cells at all to establish the staining 
background (Fig. 2, B and C). We confi  rmed that the effi   -
ciency of the take is comparable between 104 and 106 cells 
(unpublished data) and calculated the fold expansion for the 
various experimental groups. OT-I T cells in animals that re-
ceived no DT expanded more than 6,000-fold, whereas 
treatment with DT 1 h after transfer resulted in  200-fold 
expansion (Fig. 2 C). Waiting for 12 or 24 h before injecting 
DT increased OT-I numbers 3–9-fold, respectively, com-
pared with the 1-h DT-treated group.
Despite this reduction in OT-I numbers by DT treatment 
up to 24 h, we did not observe major functional diff  erences 
between the groups. OT-I T cells showed no impairment in 
their ability to traffi   c to the lung (Fig. 3 A), maintaining the 
accumulation pattern among the groups that was noted in the 
spleen. Similarly, their ability to produce IFNγ is comparable 
(Fig. 3 B), though OT-I cells from the 1 h DT group tend to 
produce less IFNγ and express higher levels of CD62L (Fig. 
3 C) than OT-I cells from the other groups.
We conclude from these results that to guarantee optimal 
expansion of CD8+ T cells, they need to be able to encounter 
their antigen for up to 54 h (treatment at 48 h after priming plus 
6 h to eliminate the vast majority of OVAp-presenting DCs). 
In contrast, less than 7 h (treatment at 1 h past priming and 6 h 
to eliminate DCs) is suffi   cient to establish functionality of eff  ec-
tors as assessed by cytokine production and tissue migration.
We went on to address which mechanisms contribute to 
the increased accumulation in mice treated with DT at later 
time points. We analyzed the CFSE profi  le of transferred 
OT-I T cells in all groups, but no apparent diff  erences were 
visible (Fig. 4 A), as all cells were CFSE negative, suggesting 
that cells in all treatment groups underwent at least seven 
rounds of division. However, we were concerned that some 
of our transferred T cells in the 1- and 12-h groups did not get 
recruited into the response, which could be masked by the 
bulk of expanding cells. To determine if recruitment of cells 
was a major factor, we took advantage of the pull-down assay, 
a recently published approach to harvest the majority of adop-
tively transferred cells (31). After enrichment of the transferred 
OT-I T cells (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20060928/DC1), we analyzed the retrieved 
cells by FACS and found that only a small fraction did not 
fully dilute their CFSE in the 1- and 12-h group (Fig. 4 B). 
The small fraction of CFSE-containing cells cannot explain 
the diff  erence between the 1- and 12-h group, and cannot 
account for the  30-fold diff  erence in numbers between the 
untreated and 1-h group (Fig. 2 C). We also confi  rmed that 
infection with 2 × 103 CFUs of WT-LM did not cause apop-
tosis of unprimed T cells (unpublished data), thus excluding 
the possibility that nonrecruited OT-I T cells are not detected 
because they were eliminated from the host (32).
We considered the possibility that CD8+ T cells encoun-
tering antigen only briefl  y might undergo seven rounds of 
division and thus fully dilute the CFSE dye (Fig. 4 A), but 
then stop or slow down proliferation. To address this issue, 
we pulsed mice with BrdU for 2 h before harvesting to ob-
tain a snapshot of their turnover on day 5. Although the cells 
of the 1-h group incorporate substantial amounts of BrdU, 
we did observe a reduction in BrdU uptake in the 1- and 
12-h groups compared with the untreated control group 
(Fig. 4 C). Although the diff  erence in turnover is likely a 
contributing factor, we cannot rule out that survival of OT-I 
T cells increases with longer antigen exposure, thus further 
potentiating the eff  ect of increased cell turnover.
Figure 4.  Proliferation but not recruitment contributes to the 
different size of the OT-I pool in DT-treated animals. (A) The CFSE 
profi  le of OT-I T cells in all groups was analyzed on day 5 after priming 
(black histogram) and compared with an unprimed control (white histo-
gram). (B) To further assess whether unrecruited, CFSE high cells are pres-
ent in our early DT-treated groups, a pull-down assay was performed (see 
Materials and methods). The panels on the left are gated on OT-I T cells 
from untreated (top), 1 h–treated (middle), or 12 h–treated (bottom) mice. 
On the right, the same data are shown on a bigger scale to facilitate de-
tection of low numbers of cells. (C) Mice were pulsed with BrdU 2 h be-
fore harvesting on day 5. Congenic OT-I T cells were analyzed for their 
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Initial experiments on CD8 programming have addressed 
the primary response of in vitro–stimulated cells and their 
ability to respond 43 d later in an IFNγ assay (7). In light of 
our fi  nding that cells that were only briefl  y stimulated display 
a decrease in accumulation and turnover, we wanted to ex-
amine the potential of these cells to respond to a rechallenge 
more closely. We chose to use a recombinant LM strain that 
expresses OVA (LM-OVA) for the rechallenge. Since all 
mice were injected with WT-LM during the primary re-
sponse, the diff  erence in OT-I T cell numbers between our 
experimental groups will not be a decisive factor in clearing 
LM-OVA. This rechallenge strategy provides a very similar 
environment in our host mice, yet allows for expansion of 
the OT-I T cells, thus ensuring a fair comparison. Mice were 
infected with 2 × 105 LM-OVA on day 35 after the primary 
infection with WT-LM and injection with OT-I cells and 
peptide-pulsed DCs, and harvested on day 3 after rechal-
lenge. We observed an expansion of OT-I T cells in all 
groups (Fig. 5, A and B). Signifi  cantly, the proportion of the 
OT-I population within the groups remained constant be-
tween the primary and secondary response (Fig. 2 C and Fig. 
5 B), suggesting that all T cells proliferated and survived at 
similar rates in the secondary response (Fig. S2, available at 
http://www.jem.org/cgi/content/full/jem.20060928/DC1). 
OT-I T cells of all groups were capable of responding in an 
IFNγ assay (Fig. 5 C) and were found in nonlymphoid tissues 
at ratios comparable to the spleen (unpublished data). It is 
noteworthy that at this point the OT-I T cells from the 1-h 
DT-treated group produce as much IFNγ as OT-I T cells 
from all other groups, hence the tendency to produce less 
IFNγ that was observed during the primary response is not 
imprinted in the memory cell response to rechallenge. Our 
data indicate that prolonged antigen exposure is required for 
an optimal primary response, but a shortened exposure in the 
primary response does not impair T cells in their ability to 
respond to a rechallenge.
DISCUSSION
Several reports established the concept of CD8+ T cell pro-
gramming after short-term antigen presentation relying on 
delivering the priming stimulus in vitro (7–9). Here we re-
port the design of a system that allowed us to study CD8+ 
T cell programming entirely in vivo. We examined the 
  relevance of the duration of TCR engagement in program-
ming the primary response and its consequences for the 
  secondary response.
We chose to deliver antigen through peptide-pulsed DCs 
carrying a transgene encoding the DTR. The DTRtg DCs 
can be effi   ciently removed by administration of the toxin 
without passing on the antigen to host APCs. This was done 
in the context of a WT-LM infection, providing a physio-
logical environment encountered during infection (Fig. 2 A). 
In this system, we found that OT-I T cells that encountered 
antigen for only 7 h receive all necessary signals to develop 
eff  ector function, including proper traffi   cking to nonlym-
phoid tissues and the ability to diff  erentiate into functional 
memory cells. These 7 h are the maximum interaction time 
possible, based on the assumption that the OT-I T cell gets 
primed by the antigen-presenting DC immediately after 
adoptive transfer and stays in contact with DCs until the lat-
ter are eliminated 6 h after administration of the toxin (Fig. 1) 
at 1 h after transfer. It is thus very likely that the actual inter-
action time between OT-I T cells and DCs is considerably 
shorter, implying that the required time span to program 
Figure 5.  Shortening antigen exposure time in the primary re-
sponse does not affect the effi  ciency of the secondary response. 
(A) 35 d after priming, mice were rechallenged with a dose of 2 × 105 
LM-OVA, harvested 3 d after rechallenge, and the magnitude of the re-
call response was assessed by analyzing the size of the OT-I pool. The 
naive OT-I group that had received 106 OT-I on day 0 remained unin-
fected. The percentage of OT-I T cells in the spleen is shown. (B) Based 
on the data shown in A, the absolute number of OT-I T cells was calcu-
lated. (C) Splenocytes were tested for their ability to produce IFNγ in a 
4-h in vitro assay. Histograms are based on a gate specifi  c for the 
  congenic OT-I T cells.JEM VOL. 203, September 4, 2006  2141 
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  eff  ector function and subsequent diff  erentiation into a mem-
ory cell is less than 7 h.
Some insight regarding the requirements for T cell pro-
gramming was provided by previous in vivo studies, though 
these were limited in their ability to terminate antigen presen-
tation at defi  ned time points. Termination of antigen presenta-
tion could not be achieved without altering other environmental 
conditions and was further complicated by the possibility that 
antigen continued to be presented through cross-presentation 
even after antibiotic mediated removal of a pathogen, thus 
making it diffi   cult to defi  ne when APCs cease to present anti-
gen. Collectively, this means that thus far we have lacked a 
clear defi  nition for the role of TCR-derived signals in pro-
moting CD8+ T cell programming in vivo. Another in vivo 
study indeed reports data that seem to contradict the program-
ming hypothesis. Storni et al. observed that CD8+ T cells re-
quire antigen for several days in vivo to produce IFNγ (33). 
However, interpretation of their data is complicated by the 
fact that in their system using virus-like particles, infl  ammation 
is rather limited, which further underlines the importance 
of studying programming in a system that dissects the roles of 
these two stimuli. Although we defi  ne the role of duration of 
antigen presentation, we do not directly address to what ex-
tent cytokines and other infl  ammatory mediators contribute to 
CD8+ T cell programming other than describing the enhanc-
ing eff  ect of cytokines and other mediators on T cell accumu-
lation (Fig. 2, B and C, no DT vs. DTRtg DC, no LM).
The ability to discontinue antigen presentation within a 
defi  ned time period allows us to discuss our fi  ndings in regard 
to a 2-photon microscopy study in live animals that showed 
that T cell priming occurs in three distinct phases  (34). The 
fi  rst phase is characterized by short-lived T cell–DC interac-
tions and lasts for  8 h. The subsequent 12 h are defi  ned by 
slower migration of the T cell and longer T–DC conjugates, 
before shortening the contact time again on the second day 
  after priming. Our data suggest that the early interactions are 
suffi   cient to instruct the T cell for functionality, but longer 
contact with DCs is needed for optimal long-term prolifera-
tion and survival. Deleting DCs with diphtheria toxin 48 h 
  after priming results in removal of the antigen within 54 h or 
less. This time span is suffi   cient to equip the T cell with its full 
functional and proliferative potential. Our 24-h DT experi-
mental group (being equal to or less than 30 h of TCR signals), 
on the other hand, showed consistently lower T cell accumu-
lation, indicating that the third phase of priming as described 
by Mempel et al., though not essential for functionality, does 
play a role in further boosting the T cell response (34). We 
considered the possibility that these later phases of priming 
might be important to equip OT-I T cells with the ability to 
home to nonlymphoid tissues. Examination of the lungs failed 
to show any evidence of an impaired traffi   cking pattern (Fig. 
3 A) regardless of the DT treatment protocol. OT-I T cells of 
all groups were found in the lung in proportion to their splenic 
abundance, illustrating that the completion of the fi  rst two 
phases of priming, as described with two photon microscopy, 
is not essential for eff  ector T cell development itself.
The potential of CD8+ T cells to accumulate depends on 
the antigen exposure time (Fig. 2, B and C). Although we 
have evidence that a slower turnover in cells that received a 
shorter antigen stimulus is a contributing factor (Fig. 4 C), 
recruitment of cells into the response does not play a role at 
the T cell to DC ratio used in our study. It is likely that cell 
survival is involved as well, though preliminary experiments 
using annexin V staining did not shed light on this issue 
  (unpublished data).
Interestingly, the diff  erences in OT-I T cell accumulation 
after the primary response between the diff  erent groups are 
still refl  ected after a rechallenge of the memory cells. One 
would expect a larger diff  erence in OT-I cell numbers be-
tween the groups after rechallenge, if OT-I memory cells 
from the 1-, 12-, and 24-h DT groups were behaving simi-
larly as they did during the primary response. Importantly, 
the diff  erences observed after the primary response are main-
tained at unaltered ratios, indicating that during the second-
ary challenge OT-I T cells from the 1-h DT group are as 
potent in proliferating and accumulating as their DT un-
treated counterparts. Prolonged TCR-mediated signals are 
thus not essential for triggering the instructional program to 
become a functional memory cell. This is confi  rmed by our 
fi  nding that OT-I T cells from untreated and 1-h DT-treated 
mice responded equally well in an IFNγ assay after rechal-
lenge (Fig. 5 C) despite the tendency of 1-h DT-treated mice 
to produce less IFNγ in the primary response. This fi  nding 
appears to be in contrast with studies that correlate a short 
antigen interaction time with induction of tolerance (11, 14, 
33). We believe that the diff  erent outcome is caused by the 
experimental setups applied and suggest that T cells that en-
counter an antigen briefl  y during an infection develop into 
fully functional memory cells, though their initial contribu-
tion to the size of the T cell pool will be limited.
Although our data add to and refi  ne studies that addressed 
CD8+ T cell programming, more work is needed to shape a 
clearer picture of CD4+ T cell programming. A recent study 
suggests that CD4+ T cells are critically dependent on con-
tinuous presentation of antigen in vivo to sustain prolifera-
tion and mediate eff  ector cell diff  erentiation in an environment 
with no or limited infl  ammation (35). This would imply that 
programming requirements for CD4+ and CD8+ T cells are 
intrinsically diff  erent. However, another study concluded 
that CD4+ T cells do undergo programming after short-term 
antigen stimulation in vitro and can proliferate in the absence 
of antigen (36). Further experiments are required to elucidate 
diff  erences between the CD8+ and CD4+ T cell subsets and 
the underlying mechanisms.
In summary, the duration of the TCR stimulus in vivo 
determines the magnitude of the primary CD8+ T cell re-
sponse, but the progeny of cells exposed to antigen for as 
short as 7 h diff  erentiate to eff  ectors, enter nonlymphoid tis-
sue, and produce memory cells. Notably, CD8+ T cells of all 
experimental groups display identical characteristics during 
the secondary response indicating that diff  erences observed 
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IFNγ production (Fig. 3 B), and turnover (Fig. 4 C) are not 
maintained in the memory stage.
MATERIALS AND METHODS
Mice. CD11c DTRtg and C57BL/6 mice were obtained from The Jackson 
Laboratory and housed in specifi  c pathogen-free conditions in the animal 
  facilities at the University of Washington. OT-I TCR transgenic mice 
  congenic for Thy1.1 and CD45.1 were bred and maintained in the same 
  facilities. Mice were infected at 8–12 wk of age. All experiments were per-
formed in compliance with the University of Washington Institutional Ani-
mal Care and Use Committee regulations.
Dendritic cell isolation. DCs were expanded in CD11c DTRtg mice 
with a Flt-3L–secreting mouse melanoma cell line as previously described 
(34). Before FACS sorting, CD3+ and CD19+ cells were depleted with 
magnetic beads (Miltenyi) to increase the percentage of CD11c+ cells. 
CD11c+ GFPhi cells were obtained by sorting on a FACSAria. CD11c+ 
  GFPhi cells were pulsed with 1 μg/ml LPS and 1 μg/ml SIINFEKL (OVAp) 
for 1 h at 37°C, washed twice, and resuspended in PBS.
DT-mediated depletion. 100 ng DT (Sigma-Aldrich) was injected i.v. 
and another 100 ng DT was injected i.p. at the time points indicated.
Adoptive transfer and cell sorting. Naive CD44low OT-I T cells were 
isolated from lymph nodes using the Miltenyi CD8 isolation kit plus anti-
CD44bio (IM-7) and CFSE labeled after the protocol previously described 
(37). OT-I T cells were resuspended in PBS and mixed with DCs immedi-
ately before i.v. adoptive transfer into recipient mice.
Bacterial infections. LM-OVA (38) and WT-LM were grown as previously 
described (13). For primary infections, mice were injected i.v. with 2 × 103 
CFU WT-LM after adoptive transfer of OT-I T cells and DCs. For secondary 
infections, mice received 2 × 105 CFU LM-OVA and were killed 3 d later.
Flow cytometry. Recipient mice were killed at the time points indicated 
and single cell suspensions were prepared from the spleen, lymph nodes, and 
lungs after perfusion of the animal. Red blood cell–depleted splenocytes 
were treated with 2.4G2.1 (Fc-block) before further staining. Cells were 
typically stained with anti-CD8, anti-CD62L, anti-IL-7Rα, anti-Thy1.1, 
and anti-CD45.1. Experiments using the pull-down assay followed the pre-
viously published protocol (31).
For intracellular staining, cells were prepared with the Cytofi  x/ 
Cytoperm kit in the presence of brefeldin A (BD Biosciences) and stained 
with anti-IFNγ PE (XMG1.2; eBioscience), anti-Thy1.1, or CD45.1 APC 
and anti-CD8 PerCP. For BrdU incorporation, BrdU was injected i.p. 2 h 
before harvesting. Cells were stained using anti–BrdU-APC antibodies ac-
cording to manufacturer’s protocol (BrdU Flow kit; BD Biosciences).
Cells were analyzed using a FACSCanto and FACSCalibur (BD Biosci-
ences) and analyzed using FLOWJO (TreeStar) software.
Online supplemental material. Fig. S1 illustrates the increase of OT-I 
T cells available for analysis by using the pull-down assay. Fig. S2 shows 
the number of OT-I memory T cells before rechallenge with LM-OVA 
on day 35. Online supplemental material is available at http://www.jem.
org/cgi/content/full/jem.20060928/DC1.
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